These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5698906)

  • 21. Studies upon the relation between plasma antithrombin and heparin; influence of plasma antithrombin on prothrombin time.
    TANTURI CA; WETZEL NC
    Am J Med Sci; 1949 Apr; 217(4):410-20. PubMed ID: 18115156
    [No Abstract]   [Full Text] [Related]  

  • 22. [Heterogeneity of mammalian antithrombin III].
    Bashkov GV; Kalishevskaia TM; Strukova SM
    Biokhimiia; 1989 Nov; 54(11):1797-803. PubMed ID: 2627551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antithrombin activity of alpha-1-protease inhibitor: the antitrypsin activity of antithrombin III.
    Learned LA; Bloom JW; Hunter MJ
    Thromb Res; 1976 Jan; 8(1):99-109. PubMed ID: 1082656
    [No Abstract]   [Full Text] [Related]  

  • 24. Hamster antithrombin III: purification, characterization and acute phase response.
    Mak P; Enghild JJ; Dubin A
    Comp Biochem Physiol B Biochem Mol Biol; 1996 Sep; 115(1):135-41. PubMed ID: 8896339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of heparin with the plasma proteins in relation to its antithrombin activity.
    Porter P; Porter MC; Shanberge JN
    Biochemistry; 1967 Jun; 6(6):1854-63. PubMed ID: 4166629
    [No Abstract]   [Full Text] [Related]  

  • 26. Heparin cofactor activity and antithrombin III concentration in plasma related to age and sex.
    Odegärd OR; Fagerhol MK; Lie M
    Scand J Haematol; 1976 Oct; 17(4):258-62. PubMed ID: 63141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Electrophoretic mobility of antithrombin III in an agarose gel with heparin. (author's transl)].
    Aiach M; Fiessinger JN; Andreux JP; Beuvin J; Housset E; Leclerc M
    Pathol Biol (Paris); 1977 Dec; 25 Suppl():35-41. PubMed ID: 353657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Progressively acting antithrombins and plasma heparin resistance in ischemic heart disease].
    Barkagan ZS; Bishevskiĭ KM; Vidiakov GE; Kungurov IA
    Kardiologiia; 1981 Aug; 21(8):31-5. PubMed ID: 7289382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of membrane adsorber (MA) based purification schemes for the down-stream processing of recombinant h-AT III.
    Reif OW; Freitag R
    Bioseparation; 1994 Dec; 4(6):369-81. PubMed ID: 7765681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and characterization of rat plasma antithrombin III.
    Takahara H; Sinohara H
    Biochim Biophys Acta; 1980 Mar; 612(1):185-94. PubMed ID: 7362830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STUDIES ON THROMBIN INACTIVATION IN NORMAL PLASMA, SERUM AND PLASMA FRACTIONS, AND ITS RELATION TO HEPARIN.
    BLOMBAECK B; BLOMBAECK M; OLSSON P
    Thromb Diath Haemorrh; 1963 Jul; 143():368-86. PubMed ID: 14081260
    [No Abstract]   [Full Text] [Related]  

  • 32. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.
    Krulder JW; Strebus AF; Meinders AE; Briët E
    Haemostasis; 1996; 26(2):85-9. PubMed ID: 9119287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of interference by heparin cofactor II in the DuPont aca antithrombin-III assay.
    Hortin GL; Tollefsen DM; Santoro SA
    Am J Clin Pathol; 1988 Apr; 89(4):515-7. PubMed ID: 3354504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin cofactor II is degraded by heparan sulfate and dextran sulfate.
    Saito A
    Biochem Biophys Res Commun; 2015 Feb; 457(4):585-8. PubMed ID: 25600805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of antithrombin III from normal and alpha1-antitrypsin-deficient human plasma.
    Borsodi AD; Bradshaw RA
    Thromb Haemost; 1977 Aug; 38(2):475-85. PubMed ID: 304258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Permanent activation of antithrombin by covalent attachment of heparin oligosaccharides.
    Björk I; Larm O; Lindahl U; Nordling K; Riquelme ME
    FEBS Lett; 1982 Jun; 143(1):96-100. PubMed ID: 7117524
    [No Abstract]   [Full Text] [Related]  

  • 37. Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest.
    Sas G; Pepper DS; Cash JD
    Thromb Diath Haemorrh; 1975 Jun; 33(3):564-72. PubMed ID: 1154312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombin III and heparin.
    Barrowcliffe TW; Johnson EA; Thomas D
    Br Med Bull; 1978 May; 34(2):143-50. PubMed ID: 350337
    [No Abstract]   [Full Text] [Related]  

  • 39. Microheterogeneity of plasma glycoproteins heparin cofactor II and antithrombin III and their carbohydrate analysis.
    Kim YS; Lee KB; Linhardt RJ
    Thromb Res; 1988 Jul; 51(1):97-104. PubMed ID: 3413738
    [No Abstract]   [Full Text] [Related]  

  • 40. [Purification of antithrombin III by affinity chromatography in heparin-Trisacryl].
    Allary M; Boschetti E; Majurel M; Girot P; Saint-Blancard J
    Ann Pharm Fr; 1986; 44(5):379-86. PubMed ID: 3579161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.